trump glp-1 medicaid President announced the popular weight loss drugs would soon be more accessible to millions of Americans at a cost of only $50 per month Trump's Plan to Expand Access

They know your complete medical history and can provide personalized guidance

Physical activity advice only or structured exercise training and association with HbA1c levels in type 2 diabetes: A systematic review and meta-analysis

inslin duyarlln artran, inflamasyon ve oksidatif stresi dolayl olarak azaltan etkileriyle biyolojik sistemlerin daha stabil almasna katk sunabilir

The ATTAIN-2 trial , scheduled for August 2025, is assessing weight loss in people with obesity who also have type 2 diabetes

, Long-term safety and efficacy of glucagon-like peptide-1 receptor agonists in individuals with obesity and without type 2 diabetes: A global retrospective cohort study, Diabetes Obes

YJZ: Conceptualization, Formal Analysis, Writingoriginal draft